Fluorescein Angiography Findings Post-intravitreal Bevacizumab for ROP: Can It Predict the Late-Onset Risk of Recurrence?

Related

• 

  Part 3: Implementing Clinical Trials in a Retina Practice: How to Get Started and Recruit Successfully (Part 3 of 3)

  Arshad M. Khanani, MD, MA, FASRS

  Carl J Danzig, MD

  Charles C Wykoff, MD, PhD, FASRS

  John D Pitcher, MD

  Nikolas JS London, MD, FACS, FASRS

  On Demand Cases, Courses, and Papers

  2018

• 

  Impact of Retinal Ischemia on Visual Acuity Outcomes

  Michael Peter Fielden, MD, FRCS(C)

  Updates from the Field

  2016

• 

  Retinal Genetics: Top 10 IRD Insights

  Daniel L Chao, MD, PhD

  Updates from the Field

  2019